Thu 4/19/2018 05:28 ET
S&P 5002708.642.170.08%BANKS27.450.130.47%OIL62.241.051.69%BITCOIN8234.0644.460.54%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Cardium Therapeutics - CXM   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add CXM
From: guinevere (Rep: 33)Date: 11/19/2012 09:52
Forum: Cardium Therapeutics - Msg #639Thread #673476623 (Rec: 0)
More DD
Generx is intended to stimulate the growth of collateral blood vessels to effectively bypass coronary artery atherosclerotic blockages without the need for surgical procedures or angioplasty and stents; and its safety and effectiveness have been the subject of clinical studies involving more than 650 patients in the U.S., Europe and elsewhere. Generx has been assigned the trade name Cardionovo(TM) for planned commercialization in the Russian Federation. Cardium believes that its Generx clinical database represents the largest and most complete gene therapy dossier.

The results of the Russian ph III trial are expected by May 2013

Live life as if you were to die tomorrow, learn as if you were to live forever.
What would you like to do? Message: Endorse | Bookmark | Report AbuseUser guinevere: Reward | Watch | IgnoreCXM: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add CXM | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999-, Inc.